(Press-News.org) Amsterdam, March 2, 2023 – The overall responsiveness of patients with chronic liver disease (CLD) to COVID-19 vaccines has been shown to be decreased in patients with cirrhosis. A new prospective study in JHEP Reports, published by Elsevier, now shows that this lower response is observed up to six months following two-dose COVID-19 mRNA vaccination, but it does not reduce vaccine efficacy.
In this prospective study, more than 350 patients with CLD were recruited in clinical centers from Austria, Belgium, Italy, Portugal, Romania, and Spain. Cirrhosis, alongside age and vaccine type, is associated with lower immunoglobulin G (IgG) responses, while the presence of viral hepatitis or antiviral therapy is associated with higher IgG responses. Noteworthy, these differences did not correlate with vaccine efficacy at six months.
Rui Castro, MD, PhD, from the Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal, explained that the consortium behind this study, HEPCOVIVac, “was brought together to create a prospective clinical registry of patients with CLD vaccinated for COVID-19, allowing for comprehensive studies on vaccination safety and efficacy.” The consortium is co-led by Helena Cortez-Pinto, MD, PhD, Centro Hospitalar Universitário Lisboa Norte and Faculty of Medicine, Universidade de Lisboa, Portugal.
Results showed that, among patients with CLD, age, cirrhosis, and type of vaccine were identified as independent predictors of lower immune response, while viral hepatitis, and antiviral therapy stood as independent predictors of higher immune response.
“While the lower response in patients with cirrhosis could relate with cirrhosis-associated immune dysfunction (CAID), and age is already a well-established factor affecting vaccine-mediated immunity, the link between viral hepatitis and higher IgG titers was interesting and warrants further study.” noted Dr. Castro.
When comparing patients who developed COVID-19 between two weeks and six months following vaccination, vaccine efficacy appeared to be slightly lower in patients with higher weight and height. Of note, no correlation was found between the type of vaccine and SARS-CoV-2 infection rates; and no association was found between IgG titers at two weeks and vaccine efficacy. In fact, Wuhan-Hu-1, B.1.617 and B.1.1.529 IgG levels were very similar between SARS-CoV-2 infected and non-infected patients. Results also showed no significant associations between clinical variables and COVID-19 infection rates or infection severity.
“We were surprised by these results, as they suggest that the distinct levels of antibodies induced by the distinct vaccine types, or associated with distinct disease etiology or severity, may not translate into lower vaccine efficacy (COVID-19 infection), at least within the first six months following two-dose vaccination,” noted Dr. Castro. “Although additional studies should ideally be performed, I think this message can already be communicated to patients. That is, that different two-dose mRNA COVID-19 vaccines are effective in a diverse group of patients with CLD. This will help to boost confidence in the vaccination plans put in place by different governments.”
Notwithstanding, results also showed that patient IgG levels against the B.1.617 and, further, the B.1.1.529 variant, were decreased compared with Wuhan-Hu-1, at two weeks following vaccination. This differential pattern was maintained after six months, but with significantly lower antibody titers for all variants, particularly in patients with cirrhosis, in contrast to the results of healthy volunteers.
“These results highlight the need for patients with CLD, particularly those older and with cirrhosis, to receive booster shots” noted Dr. Castro. “Ideally, patients should be prioritized for adapted vaccines against recent omicron variants, although studies on the efficacy of adapted vaccines in patients with CLD are still lacking.”
END
Liver cirrhosis is associated with a lower immune response to COVID-19 vaccines but not with reduced vaccine efficacy
New study of chronic liver disease patients in JHEP Reports shows age, cirrhosis & vaccine type predict “lower” immune response; viral hepatitis etiology & prior antiviral therapy predict “higher” immune response to 2-dose COVID-19 mRNA vaccines
2023-03-02
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Human norovirus GII.4 exploits unexpected entry mechanism to cause gastroenteritis
2023-03-02
Human noroviruses are the leading cause of acute gastroenteritis worldwide, a major global health problem for which there are no specific treatments or vaccines. Understanding the first phase of infection – the process the virus follows to invade cells – is a decisive step in the development of effective preventive and therapeutic strategies. A team led by researchers at Baylor College of Medicine is making strides in that direction.
The researchers report in the journal Nature Communications that the globally dominant human norovirus GII.4 strain invades gastrointestinal cells via an unexpected mechanism. The viral strategy involves interactions ...
AI predicts cancer patient survival by reading doctor's notes
2023-03-02
A team of researchers from the University of British Columbia and BC Cancer have developed an artificial intelligence (AI) model that predicts cancer patient survival more accurately and with more readily available data than previous tools.
The model uses natural language processing (NLP) – a branch of AI that understands complex human language – to analyze oncologist notes following a patient’s initial consultation visit—the first step in the cancer journey after diagnosis. By identifying characteristics unique to each ...
For older adults, every 500 additional steps taken daily associated with lower heart risk
2023-03-02
Research Highlights:
A study of people ages 70 and older found walking an additional 500 steps per day, or an additional quarter mile of walking, was associated with a 14% lower risk of heart disease, stroke or heart failure.
Compared to adults who took less than 2,000 steps per day, adults who took about 4,500 steps per day had a 77% lower observed risk of experiencing a cardiovascular event.
Only about 3.5% of participants who took around 4,500 steps per day had a cardiovascular event, compared to 11.5% of those who took less than 2,000 steps per day, over the 3.5-year follow-up period.
Embargoed until 10:45 a.m. CT/11:45 a.m. ET, ...
American Society for Metabolic and Bariatric Surgery supports new clinical guidance on treatment of obesity in children and teens
2023-03-02
The American Society for Metabolic and Bariatric Surgery (ASMBS) fully supports the new “Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity” issued from the American Academy of Pediatrics (AAP) calling for earlier and more intensive treatment of obesity in children and teens. Published in the journal Pediatrics in February, this is the first comprehensive guideline on obesity in 15 years from the AAP, the largest professional association of pediatricians in the U.S.
According to AAP, more evidence ...
Many firearm owners in the U.S. store at least one gun unlocked, fearing an emergency
2023-03-02
Most firearm owners keep at least one firearm unlocked, with some viewing gun locks as an unnecessary obstacle to quick access in an emergency, according to a Rutgers study. But when they do lock their firearms, Rutgers researchers found that firearm owners are most likely to use gun safes.
In a study published in JAMA Network Open and funded by the Defense Health Agency, researchers surveyed a national sample of 2,152 English-speaking adult firearm owners, asking them what locking devices they used and why.
Unlike previous studies, participants were presented with both words and images describing each ...
To ensure a safe and just future for people, nature and the planet, Earth System Boundaries must include justice, researchers find
2023-03-02
In a new study published in Nature Sustainability an international team of scientists from the Earth Commission, convened by Future Earth, investigates how global biophysical boundaries need to be adjusted to ensure a safe and just future for people, nature and the planet. The Earth Commission is the scientific cornerstone of the Global Commons Alliance
This new framework integrates methods to reduce harm to people, increase access to resources, address tradeoffs, and challenge powerful interests whilst addressing inequality between generations and between humans and nature ...
Genomic study of indigenous Africans paints complex picture of human origins and local adaptation
2023-03-02
Africa, where humans first evolved, today remains a place of remarkable diversity. Diving into that variation, a new analysis of 180 indigenous Africans from a dozen ethnically, culturally, geographically, and linguistically varied populations by an international scientific team offers new insights into human history and biology, and may inform precision medicine approaches of the future.
The work clarifies human migration histories, both historical and more recent, and provides genetic evidence of adaptation to local environments, ...
Energy: More than two million citizens power Europe’s renewable energy transition
2023-03-02
More than two million citizens across 30 European countries have been involved in thousands of projects and initiatives as part of efforts to transition to renewable energy, according to an analysis published in Scientific Reports. With investments ranging between 6.2 and 11.3 billion Euros, these findings highlight the important role of collective action in the decarbonisation of Europe.
The energy system in Europe is undergoing a significant transition towards renewables and decarbonisation. However, the contribution ...
Performance of outpatient surgical procedures before, after onset of pandemic
2023-03-02
About The Study: The findings of this study suggest that despite calls for the expansion of outpatient surgery to mitigate the growing backlog of surgical cases in the wake of the COVID-19 pandemic, uptake of this practice occurred in only a small subset of operations. Further studies should explore potential barriers to the uptake of this approach, particularly for procedures that have been shown to be safe when performed in an outpatient setting.
Authors: Cornelius A. Thiels, D.O., M.B.A., of the Mayo Clinic in Rochester, Minnesota, is the corresponding author
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.1198)
Editor’s ...
Trends, variation in the use of active surveillance for management of low-risk prostate cancer
2023-03-02
About The Study: The results of this study of more than 20,000 men with low-risk prostate cancer suggest that active surveillance rates are rising nationally but are still suboptimal, and wide variation persists across practices and practitioners. Continued progress on this critical quality indicator is essential to minimize overtreatment of low-risk prostate cancer and by extension to improve the benefit-to-harm ratio of national prostate cancer early detection efforts.
Authors: Matthew R. Cooperberg, M.D., M.P.H., of the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, is the corresponding ...
LAST 30 PRESS RELEASES:
Understanding bias and discrimination in AI: Why sociolinguistics holds the key to better Large Language Models and a fairer world
Safe and energy-efficient quasi-solid battery for electric vehicles and devices
Financial incentives found to help people quit smoking, including during pregnancy
Rewards and financial incentives successfully help people to give up smoking
HKU ecologists reveal key genetic insights for the conservation of iconic cockatoo species
New perspective highlights urgent need for US physician strike regulations
An eye-opening year of extreme weather and climate
Scientists engineer substrates hostile to bacteria but friendly to cells
New tablet shows promise for the control and elimination of intestinal worms
Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston
Depression – discovering faster which treatment will work best for which individual
Breakthrough study reveals unexpected cause of winter ozone pollution
nTIDE January 2025 Jobs Report: Encouraging signs in disability employment: A slow but positive trajectory
Generative AI: Uncovering its environmental and social costs
Lower access to air conditioning may increase need for emergency care for wildfire smoke exposure
Dangerous bacterial biofilms have a natural enemy
Food study launched examining bone health of women 60 years and older
CDC awards $1.25M to engineers retooling mine production and safety
Using AI to uncover hospital patients’ long COVID care needs
$1.9M NIH grant will allow researchers to explore how copper kills bacteria
New fossil discovery sheds light on the early evolution of animal nervous systems
A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior
Study shows how plant roots access deeper soils in search of water
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
‘What is that?’ UCalgary scientists explain white patch that appears near northern lights
How many children use Tik Tok against the rules? Most, study finds
Scientists find out why aphasia patients lose the ability to talk about the past and future
Tickling the nerves: Why crime content is popular
Intelligent fight: AI enhances cervical cancer detection
Breakthrough study reveals the secrets behind cordierite’s anomalous thermal expansion
[Press-News.org] Liver cirrhosis is associated with a lower immune response to COVID-19 vaccines but not with reduced vaccine efficacyNew study of chronic liver disease patients in JHEP Reports shows age, cirrhosis & vaccine type predict “lower” immune response; viral hepatitis etiology & prior antiviral therapy predict “higher” immune response to 2-dose COVID-19 mRNA vaccines